Skip to main content
. 2020 Dec 10;8:599389. doi: 10.3389/fcell.2020.599389

FIGURE 6.

FIGURE 6

Immunoblot analysis for SIRT1 expression in the hippocampus. SIRT1 expression was downregulated after scopolamine treatment, which was reversed by 0.03 mg/kg BPN14770 (A). Pre-treatment with H89 (B) or Sirtinol (C) prevented the therapeutic effects of BPN14770. Results are displayed as mean ± S.E.M. (n = 4–5 per group). ∗∗P < 0.01 and ∗∗∗P < 0.001 vs. vehicle-treated control group; ##P < 0.01 and ###P < 0.001 vs. vehicle-treated scopolamine group; $$$P < 0.001 vs. BPN-treated scopolamine group. Rol, rolipram; Sirt, Sirtinol.